Medaffcon’s Market Access team provides a vantage point to the entire industry
The Market Access team works actively with different actors, while helping customers in processes related to market access and market presence and in strategic planning.
Comprehensive solutions for implementing risk-sharing models.
Confidential price agreements have become more widespread with regard to hospital medicines, while decisions on conditional reimbursement are becoming more established in the price and reimbursement processes of outpatient medicines.
Confidential agreements can be risk-sharing agreements (for example, pay for performance, conditional treatment continuation, or other contracts that reward the patient for the benefit of the treatment) or a method for sharing and managing uncertainty about the cost and effectiveness of medicines to the satisfaction of both parties. This will eventually make the medicine available to those patients who will benefit from it.
The Market Access team works actively with different actors, while helping customers in processes related to market access and market presence and in strategic planning.
Heini Honkanen has been appointed as Medaffcon’s Market Access Lead. The new Market Access Team was created when the previous Price and Reimbursement and HE & Access Teams were merged.
Medaffconin Tanja Nieminen ja Heini Honkanen osallistuivat terveystaloustieteen tutkimukseen ja terveydenhuollon menetelmien arviointiin keskittyvään ISPOR-kongressiin marraskuussa.
Managing Director
MSc (Economics)
+358 40 139 4001
jarmo.hahl@medaffcon.fi
Jarmo joined Medaffcon as a partner and CEO in 2010, having previously worked in various expert and management positions in pharma companies for eight years. Jarmo has a degree in economics and before entering the pharmaceutical industry, he held an office at the Turku School of Economics and also worked as a research fellow at Turku University Hospital.
Jarmo has strong expertise in new health technology innovations and how the demands and expectations of authorities, markets and customers are matched. He also brings to Medaffcon extensive experience in health economics and its applications in research and commercialization, as well as a broad understanding of the ever-changing operating environment.
“From an access point of view, the Finnish health technology market is constantly becoming more demanding and therefore also more attractive from my point of view. On the other hand, increasing demands to demonstrate the effectiveness and cost-effectiveness of healthcare are broadening the scope and opportunities for Medaffcon to be involved in the development of healthcare as a whole”.